UCB Selects Medidata Clinical Cloud
April 26th 2017Medidata’s Cutting-Edge Technology Platform to Drive Operational Excellence and Patient Value for Global BiopharmaNew York, NY – Medidata, the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that UCB has selected the Medidata Clinical Cloud as its enterprise technology platform.
Coalition for Clinical Trials Awareness Hosts Roundtable
April 25th 2017The Coalition for Clinical Trials Awareness will host a Capitol Hill policy roundtable featuring industry professionals on Wednesday, May 3rd. This event is part of the nationwide Clinical Trials Awareness Week taking place from May 1-5th.Read the full release here
Non-Adherence: A Direct Influence on Clinical Trial Duration and Cost
April 24th 2017As clinical trials remain costly and continue to increase, the promise of novel initiatives gives hope that trial duration and cost impact will drop. However, biopharma continues to overlook one element that affects study timelines: patient non-adherence.
Cliantha Research Acquires Inflamax Research
April 24th 2017Cliantha Research has announced the acquisition of Inflamax Research. Inflamax aims to use its inflammatory disease research and natural allergen Environmental Exposure Chambers (EEC) to assist Cliantha in conducting asthma, allergy, ophthalmology and tobacco research plus specialized pulmonary/respiratory therapeutic studies.Read the full release here
Cliantha Research Acquires Inflamax Research
April 24th 2017Cliantha Research is proud to announce the acquisition of Inflamax Research. Inflamax has locations in Toronto, ON; Neptune, NJ and Newark, NJ. Cliantha Research will have the capabilities to perform Phase I, II, III and IV clinical research in North America. Inflamax’s world renowned expertise in inflammatory disease research and patented natural allergen Environmental Exposure Chambers (EEC) shall allow Cliantha to conduct Asthma, Allergy, Ophthalmology, Tobacco research plus specialized pulmonary/respiratory therapeutic studies.